A phase I, randomized, double blind, placebo-controlled study of fevipiprant single dose administration in healthy subjects

Trial Profile

A phase I, randomized, double blind, placebo-controlled study of fevipiprant single dose administration in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Fevipiprant (Primary)
  • Indications Allergic asthma; Atopic dermatitis
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 24 Aug 2016 New trial record
    • 01 Jul 2016 Results of this and other trial published in the Clinical Pharmacology in Drug Development.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top